Suraj Madhavan – Innvocept Global Solutions
View Detailed Executive Profile →Professional Overview
- Suraj Madhavan co-founded Innvocept Global Solutions in September 2018, taking on the role of Chief Operating Officer, where efforts are focused on providing innovative solutions in the global healthcare landscape.
- Prior to Innvocept, Suraj served as Assistant General Manager in the Global Clinical Operations Department at Mylan from September 2016 to August 2018, contributing to the management of clinical trial operations across multiple regions.
- At PAREXEL, Suraj held two key positions: first as Clinical Operations Leader from July 2011 to October 2013, followed by Senior Clinical Operations Leader from November 2013 until September 2016, leading clinical teams in the execution of trials for new drug developments.
- Earlier experience includes the role of Associate Clinical Project Manager at Quintiles from April 2011 to March 2011, overseeing project management activities for clinical studies.
- Suraj also served as Associate Clinical Team Lead at Quintiles from April 2009 to March 2011, which involved coordinating team activities and progressing clinical trials effectively.
- Starting the career as Senior CRA at Quintiles from April 2008 to March 2009, responsibilities included monitoring clinical sites and ensuring compliance with regulatory standards.
- Experience also includes serving as Scientist II at Torrent Pharmaceuticals Ltd from July 2004 to December 2006, working on pharmaceutical product development and research initiatives.
- Suraj Madhavan has consistently demonstrated expertise in clinical operations and project management across several leading pharmaceutical companies, achieving significant milestones in clinical trial management and operations.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Mylan | Assistant General Manager, Global Clinical Operations Department | Sep 2016 – Aug 2018 |
| PAREXEL | Senior Clinical Operations Leader | Nov 2013 – Sep 2016 |
| PAREXEL | Clinical Operations Leader | Jul 2011 – Oct 2013 |
| Torrent Pharmaceuticals Ltd | Scientist II | Jul 2004 – Dec 2006 |
| Quintiles | Associate Clinical Project Manager | Apr 2011 – Jun 2011 |
| Quintiles | Associate Clinical Team Lead | Apr 2009 – Mar 2011 |
| Quintiles | Senior CRA | Apr 2008 – Mar 2009 |
| INNVOCEPT GLOBAL SOLUTIONS | Co-Founder and Chief Operating Officer | Sep 2018 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Innvocept Global Solutions corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Suraj Madhavan's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Innvocept Global Solutions's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)